CD8A and pancreatic neoplasm: Moreover, in resistant pancreatic tumors in orthotopic pancreatic cancer (PaC) mouse models, the simultaneous presence of more depleted effector CD8+T cells and increased M2-like TAMs with a reduced capacity for antigen presentation has been reported [77].